COVID-19 vaccination, infection, and symptoms among cancer survivors in the United States
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cancer survivors were more likely to be vaccinated against COVID-19 but experienced more severe symptoms upon infection. Tailored prevention and control strategies are needed for this vulnerable population.
Area Of Science
- Oncology
- Infectious Diseases
- Public Health
Background
- The impact of the COVID-19 pandemic on cancer survivors remains under-documented, particularly during periods of widespread vaccine availability.
- Cancer survivors represent a vulnerable population that may experience differential outcomes from COVID-19 infection and vaccination.
Purpose Of The Study
- To examine COVID-19 vaccination rates, infection history, and symptom severity among cancer survivors compared to adults without a cancer history in the United States.
- To identify demographic and clinical factors associated with vaccination status and symptom severity in cancer survivors during the COVID-19 pandemic.
Main Methods
- Analysis of nationally representative survey data from 2021 and 2022.
- Comparison of COVID-19 vaccination, infection, and symptom data between cancer survivors and adults without a cancer history.
- Statistical analysis to identify factors associated with vaccination rates and symptom severity in cancer survivors.
Main Results
- Cancer survivors showed higher rates of at least two COVID-19 vaccines compared to non-survivors in both 2021 and 2022.
- COVID-19 infection rates were similar between groups, but cancer survivors were more likely to develop moderate to severe symptoms if infected.
- Lower vaccination rates in cancer survivors were linked to younger age, lower education, lack of insurance, and more comorbidities. Female sex and younger age were associated with increased symptom severity upon infection.
Conclusions
- Cancer survivors exhibit distinct patterns of COVID-19 vaccination and infection outcomes.
- Findings underscore the need for targeted public health interventions to enhance COVID-19 prevention and management for cancer survivors.
- Tailored strategies are crucial to address disparities in vaccination and mitigate severe outcomes among cancer survivors.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Overview
Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...